Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CMRXX vs. QAAAJX: which is better?

Bottom line

CMRXX vs QAAAJX: the short answer

CMRXX (Columbia Government Money Market Fund) and QAAAJX (T. Rowe Price Blue Chip Growth Portfolio) are both money market funds.

CMRXX is cheaper at 0.34% vs 0.75% — a difference of $41 a year per $10,000 invested.

Over five years, QAAAJX returned +11.7% a year vs +2.3% for CMRXX (reporting dates differ).

Updated Nov 19, 2026

CMRXX vs QAAAJX side by side

CMRXXQAAAJX
TypeMoney market fundMoney market fund
Fund familyColumbia ThreadneedleT. Rowe Price
CategoryMoney MarketMoney Market
Expense ratio0.34%0.75%
Annual cost per $10k$34$75
10-yr cost on $10k (prospectus)$431$930
Max front load0%—
12b-1 fee0%0%
1-yr return+5.1%+18.7%
5-yr return (annualized)+2.3%+11.7%
10-yr return (annualized)+1.6%+15.5%
Best quarter—+27.6%
Worst quarter—−25.0%
Net assets (fund)—$2.5B
Number of holdings—78
Portfolio turnover—18%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CMRXX and QAAAJX share none of their top holdings.

CMRXX top 10

    QAAAJX top 10

    1. Nvidia Corp — 15.74%
    2. Alphabet Inc Cl C — 6.24%
    3. Broadcom Inc — 5.90%
    4. Alphabet Inc Cl A — 5.78%
    5. Apple Inc — 4.40%
    6. Microsoft Corp — 4.33%
    7. Advanced Micro Devices — 3.54%
    8. Meta Platforms Inc-class A — 3.47%
    9. Amazon.com Inc — 3.24%
    10. Carvana Co — 3.18%

    FAQ

    What is the difference between CMRXX and QAAAJX?
    CMRXX (Columbia Government Money Market Fund) and QAAAJX (T. Rowe Price Blue Chip Growth Portfolio) are both money market funds. CMRXX is cheaper at 0.34% vs 0.75% — a difference of $41 a year per $10,000 invested.
    Which is cheaper, CMRXX or QAAAJX?
    CMRXX has the lower expense ratio (0.34%).
    Should I own both CMRXX and QAAAJX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.